Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-026071

Chief Commercial Officer sold 2,050 shares at $85.95 ($176,198)

  • Chief Commercial Officer acquired 2,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hoerter Steven L. Chief Commercial Officer 2018-04-23 Option exercise +2,050 $39.76 $81,508 2,050 D
Hoerter Steven L. Chief Commercial Officer 2018-04-23 Sale −2,050 $85.95 $176,198 0 D
Derivatives
Hoerter Steven L. Chief Commercial Officer 2018-04-23 Option exercise · Stock option (right to buy) −2,050 68,850 D
Open-market sales · 2,050 sh · avg $85.95 · $176,198
Loading xslF345X03/doc4.xml…